The award, which will be given at the MassBio Annual Meeting […] Most recently he exercised 1,878 units of … He is also on the board of Biotechnology Innovation Organization (former Chairman), Agios Pharmaceuticals, Inc. (former Chairman) and Tempero Pharmaceuticals, Inc. Alnylam Pharmaceuticals executives and other stock owners filed with the SEC include: Prior to Alnylam, he held positions at Millennium Pharmaceuticals, Biogen (where he co-invented bivalirudin), Zymogenetics, and The Upjohn Company. Chairman and CEO of Merck & Co., Inc. BAD 1 - 2 POOR 2 - 3 FAIR 3 - 4 GOOD 4 - 5. Chief Executive Officer Since 2002, Dr. John Maraganore has served as the CEO and a Director of Alnylam. As a full-service talent booking agency, we have access to virtually any speaker or celebrity in the world. Prior to Alnylam, Dr. Maraganore served as an officer and a member of the management team for Millennium Pharmaceuticals, Inc. President & CEO of the Association of American Medical... There are 10 older and 2 younger executives at Alnylam Pharmaceuticals. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. Prior to Biogen, Dr. Maraganore was a scientist at ZymoGenetics, Inc., and the Upjohn Company.Maraganore received his MS and PhD in biochemistry and molecular biology at the University of Chicago.He is a member of the BIO Executive Committee, the Chair of the Board for Agios Pharmaceuticals, and Chair of the Biotechnology Industry Organization (BIO) Board. There are no executives at Alnylam Pharmaceuticals getting paid more. John Maraganore is a keynote speaker and industry expert who speaks on a wide range of topics. Non è possibile visualizzare una descrizione perché il sito non lo consente. All American Entertainment (AAE) exclusively represents the interests of talent buyers, and does not claim to be the agency or management for any speaker or artist on this site. Prior to Alnylam, he held positions at Millennium Pharmaceuticals, Biogen (where he co-invented bivalirudin), Zymogenetics, and The Upjohn Company.
The oldest executive at Alnylam Pharmaceuticals, Inc. is Phillip Sharp, 75, who is the Independent Director. This is Me - Control Profile. As a full-service talent booking agency, we have access to virtually any speaker or celebrity in the world. For the most current fee to hire John Maraganore, please fill out the All American Entertainment has successfully secured celebrity talent like John Maraganore for clients worldwide for more than 15 years. For more information on how we work and what makes us unique, please read the AAE Advantage.Alnylam's John Maraganore discusses the BIO FDA Survey Initiative ...John Maraganore, Ph.D., Chief Executive Officer, Alnylam ...BIO Buzz Center with John Maraganore, CEO and Director of AlnylamOur booking agents have successfully helped clients around the world secure talent like John Maraganore for both live and virtual events for over 15 years. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A.
Chief Executive Officer, Regeneron Pharmaceuticals Photos | Summary | Follow.
It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. John has made over 65 trades of the Alnylam Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. The estimated Net Worth of John Maraganore is at least The largest trade he's ever made was exercising 120,000 units of Alnylam Pharmaceuticals stock on 16 June 2009 worth over $57,600. John M. Maraganore is a businessperson who has been at the head of 5 different companies and holds the position of Chief Executive Officer & Director at Alnylam Pharmaceuticals, Inc. Our CEO John Maraganore recently spoke with Biotechnology Innovation Organization (BIO) CEO and Chairman Jim Greenwood on the "I Am BIO" podcast. Since 2002, Dr. John Maraganore has served as the CEO and a Director of Alnylam. John Maraganore in "Biotechnology in the Time of COVID-19: Commentaries from the Front Line" June 9, 2020. We do not handle requests for donation of time or media requests for interviews, and cannot provide celebrity contact information.If you are the talent, and wish to request removal from this catalog or report an issue with your profile, please Our booking agents have successfully helped clients around the world secure talent like John Maraganore for both live and virtual events for over 15 years.
The oldest executive at Alnylam Pharmaceuticals, Inc. is Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. John Maraganore is 57, he's been the Chief Executive Officer und Director of Alnylam Pharmaceuticals since 2007. Criminal or Civil Court records found on John's Family, Friends, Neighbors, or Classmates View Details. A listing or profile on this website does not imply an agency affiliation or endorsement by the talent. President & Chief Executive Officer of RWJ Barnabas Health Please provide the email address you used to create for your account. The team at All American Entertainment represents and listens to the needs of organizations and corporations seeking to hire keynote speakers, celebrities or entertainers for speaking engagements, personal appearances, product endorsements, or corporate entertainment. The largest trade he's ever made was exercising 120,000 units of Alnylam Pharmaceuticals stock on 16 June 2009 worth … View Photos. John Maraganore is 57, he's been the Chief Executive Officer and Director of Alnylam Pharmaceuticals since 2007. Alnylam Pharmaceuticals executives and other stock owners filed with the SEC include: John has made over 65 trades of the Alnylam Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC.